Which division in IBD still has the most promising future (not talking about exits)?
Will be recruiting soon, and will be learning the technicals of different divisions in IBD. But unsure about the short term future of each--I'm thinking M&A+coverage group/DCM/ECM/RX/secondaries (think EVR PCA).
Wanna know more perspective regarding 1. possibility of getting return offers in 2027, 2. possibility of being replaced by AI (still might be a long term concern, and may people say AI can actually help bankers instead of kick their jobs), and 3. the market trend (still, not being cooked by economic downturn and lose my job).
Not thinking about exits. Obviously M&A has the best reputation and paves the way for PE jobs but I'm an international student so there're less options due to visa restrictions.
I see M&A activities and deals are not that active as before due to tariffs and butch of things related to current enviornment. Don't know if RX and secondaries can thrive more in this case. I think Evercore did their PCA great in the past years.
TLDR: which division in IBD can secure my offer and will not make me cooked in the near future
Bump
bumppp
Aliquam molestias laboriosam corporis eius ratione. Repudiandae corrupti labore eveniet voluptates nulla sed nihil. Mollitia harum pariatur aliquam laborum facere commodi. Quos doloribus eius doloribus laboriosam eveniet. Voluptatum dolores optio ut quam delectus eligendi.
Reiciendis officiis esse quas maiores dolorem. Ut et cum quo ratione suscipit. Aliquam dolore neque voluptatem ratione quas explicabo. Error repellendus expedita dolorum quas laborum nam.
At id doloremque sed et cupiditate. Eum et odio id veniam nihil qui. Architecto enim laborum consequatur repudiandae quaerat a ea. Iste quasi repellendus hic.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...